Pharmacielo Ltd (V:PCLO) — Stock Price
Pharmacielo Ltd (V:PCLO) is currently trading at CA$0.07 CAD, down 13.33% today. Over the past 52 weeks, shares have ranged between CA$0.04 and CA$0.14. This page tracks Pharmacielo Ltd's live share price on the V exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see Pharmacielo Ltd market cap and net worth.
Pharmacielo Ltd (PCLO) Stock Price Chart — Daily History & Trading Volume
The chart below tracks Pharmacielo Ltd's daily closing share price and trading volume on the V exchange over the past year, giving a clear view of recent price momentum and liquidity.
Pharmacielo Ltd Income Statement — Revenue, Profit & Earnings by Year
Pharmacielo Ltd's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | CA$3.48 Million | CA$1.54 Million | CA$5.31 Million | CA$1.94 Million | CA$2.65 Million |
| Cost of Revenue | CA$2.75 Million | CA$2.91 Million | CA$4.48 Million | CA$6.25 Million | CA$9.45 Million |
| Gross Profit | CA$730.88K | CA$-1.37 Million | CA$827.06K | CA$-4.31 Million | CA$-6.80 Million |
| Research & Development | — | — | — | — | — |
| SG&A | CA$5.42 Million | CA$8.31 Million | CA$10.70 Million | CA$17.94 Million | CA$31.21 Million |
| Total Operating Expenses | CA$8.38 Million | CA$11.58 Million | CA$12.26 Million | CA$20.89 Million | CA$36.62 Million |
| Operating Income | CA$-4.90 Million | CA$-10.04 Million | CA$-11.46 Million | CA$-25.46 Million | CA$-43.12 Million |
| EBITDA | — | — | CA$-9.88 Million | CA$-24.21 Million | CA$-41.55 Million |
| EBIT | — | — | CA$-11.46 Million | CA$-25.46 Million | CA$-43.12 Million |
| Interest Expense | CA$3.27 Million | CA$2.69 Million | CA$1.54 Million | CA$561.29K | CA$272.73K |
| Income Before Tax | CA$-9.14 Million | CA$-16.30 Million | CA$-14.52 Million | CA$-26.63 Million | CA$-43.76 Million |
| Income Tax Expense | — | — | CA$1.52 Million | CA$288.00K | CA$504.42K |
| Net Income | CA$-9.14 Million | CA$-16.30 Million | CA$-16.04 Million | CA$-26.92 Million | CA$-44.26 Million |
Pharmacielo Ltd Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes Pharmacielo Ltd's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | CA$18.39 Million | CA$22.29 Million | CA$25.12 Million | CA$35.96 Million | CA$44.02 Million |
| Total Current Assets | CA$2.44 Million | CA$3.33 Million | CA$4.02 Million | CA$9.20 Million | CA$12.52 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | — | CA$0.00 | CA$153.00K | CA$291.00K | CA$750.05K |
| Net Receivables | CA$343.98K | CA$229.12K | CA$670.66K | CA$565.19K | CA$924.08K |
| Inventory | CA$1.50 Million | CA$2.31 Million | CA$2.13 Million | CA$2.28 Million | CA$1.25 Million |
| Property, Plant & Equipment | — | — | — | CA$26.12 Million | CA$30.82 Million |
| Goodwill | — | — | — | — | CA$0.00 |
| Total Liabilities | CA$25.91 Million | CA$23.97 Million | CA$18.72 Million | CA$16.63 Million | CA$17.78 Million |
| Total Current Liabilities | CA$21.23 Million | CA$21.42 Million | CA$6.95 Million | CA$8.07 Million | CA$12.06 Million |
| Long-term Debt | CA$4.68 Million | CA$2.55 Million | CA$11.73 Million | CA$7.14 Million | CA$3.06 Million |
| Net Debt | CA$20.38 Million | CA$18.21 Million | CA$12.41 Million | CA$3.09 Million | CA$-4.39 Million |
| Total Stockholder Equity | CA$-7.52 Million | CA$-1.68 Million | CA$6.39 Million | CA$19.33 Million | CA$26.25 Million |
| Retained Earnings | CA$-207.85 Million | CA$-198.71 Million | CA$-182.41 Million | CA$-167.90 Million | CA$-141.27 Million |
Pharmacielo Ltd Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how Pharmacielo Ltd generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | CA$-1.97 Million | CA$-5.15 Million | CA$-9.71 Million | CA$-20.07 Million | CA$-22.56 Million |
| Capital Expenditures | CA$0.00 | CA$15.27K | CA$521.86K | CA$1.14 Million | CA$5.43 Million |
| Free Cash Flow | CA$-1.97 Million | CA$-5.17 Million | CA$-10.23 Million | CA$-21.21 Million | CA$-28.00 Million |
| Investing Cash Flow | — | — | — | CA$-1.66 Million | CA$-5.57 Million |
| Financing Cash Flow | CA$2.02 Million | CA$4.63 Million | CA$5.30 Million | CA$18.21 Million | CA$23.32 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | CA$1.04 Million | CA$1.54 Million | CA$2.21 Million | CA$6.82 Million | CA$6.48 Million |
| Depreciation | CA$1.27 Million | CA$1.41 Million | CA$1.58 Million | CA$1.26 Million | CA$1.57 Million |
| Change in Cash | CA$91.25K | CA$-129.86K | CA$-5.17 Million | CA$-3.52 Million | CA$-4.81 Million |
Pharmacielo Ltd Earnings History — EPS Actual vs. Analyst Estimates
Track Pharmacielo Ltd's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Feb 23, 2026 | — | — | — |
| Dec 01, 2025 | — | — | — |
| Jul 16, 2025 | — | — | — |
| Jun 30, 2025 | — | — | — |
| Feb 19, 2025 | — | — | — |
| Nov 27, 2024 | — | — | — |
| May 29, 2023 | -0.06 | -0.03 | -100.00% |
| Oct 31, 2022 | -0.03 | — | — |